Browsing Category
Featured Articles
uniQure Reports Early Promise for Epilepsy Gene Therapy
uniQure has reported encouraging early clinical results from its experimental gene therapy AMT-260, offering new hope for patients living with refractory mesial temporal lobe epilepsy…
Read More...
Read More...
Jazz and AbCellera Partner on Cancer Antibody Therapies
Jazz Pharmaceuticals and AbCellera have entered into a new research collaboration aimed at developing next-generation antibody-based treatments for gastrointestinal (GI) cancers and…
Read More...
Read More...
Biogen to Acquire RayThera in $1 Billion Deal
Biogen has agreed to acquire private biotechnology company RayThera in a deal valued at up to $1 billion, strengthening the company's growing focus on immunology and expanding its…
Read More...
Read More...
Lilly Acquires 4E Therapeutics to Advance Pain Treatments
Eli Lilly and Company has acquired 4E Therapeutics, a privately held neuroscience biotechnology company focused on developing next-generation therapies for chronic pain, strengthening…
Read More...
Read More...
Johnson & Johnson Invests $1 Billion in Vision Expansion
Johnson & Johnson has announced plans to invest more than $1 billion in Jacksonville, Florida, to expand its Vision business operations and strengthen domestic manufacturing,…
Read More...
Read More...
FDA Grants Priority Review for Tecentriq in Colon Cancer
Roche has moved a step closer to expanding the use of its immunotherapy Tecentriq® (atezolizumab) in early-stage colon cancer after the U.S. Food and Drug Administration (FDA) accepted…
Read More...
Read More...
UK Approves First Oral Wegovy for Weight Management
The United Kingdom has become the first country in Europe to approve Wegovy® pill (semaglutide tablets) for weight management, providing adults living with obesity or overweight a new…
Read More...
Read More...
GSK to Acquire Nuvalent in $10.6 Billion Oncology Deal
GSK has agreed to acquire clinical-stage biotechnology company Nuvalent for approximately $10.6 billion, strengthening its oncology portfolio with a trio of targeted lung cancer…
Read More...
Read More...
FDA Grants Priority Review to Roche’s Giredestrant
Roche has moved a step closer to bringing a potential new treatment option to patients with early-stage breast cancer after the U.S. Food and Drug Administration (FDA) accepted the…
Read More...
Read More...
FDA Grants Priority Review to Sanofi’s Gaucher Disease Drug
Sanofi has received a significant regulatory boost after the U.S. Food and Drug Administration (FDA) granted priority review to the new drug application (NDA) for venglustat, an…
Read More...
Read More...
Pfizer and Innovent Partner on $10.5 Billion Cancer Drug Collaboration
Innovent Biologics and Pfizer have entered into a major global oncology collaboration aimed at accelerating the development of next-generation cancer therapies, with a deal potentially…
Read More...
Read More...
Novo Study Highlights Persistent Cardiovascular Inflammation Risk
Novo Nordisk presented new findings from its landmark POSEIDON real-world evidence study showing that cardiovascular inflammation remains highly prevalent among people living with…
Read More...
Read More...
SK bioscience, Colombia Partner on Vaccine Manufacturing Initiative
SK bioscience has signed an agreement with Colombia’s state-owned pharmaceutical company VECOL to support vaccine technology transfer and local manufacturing, marking a significant step…
Read More...
Read More...
Lilly Reports Positive Early Results for VERVE-102
Eli Lilly and Company reported positive interim results from the Phase 1b Heart-2 clinical study of VERVE-102, an investigational gene-editing therapy designed to lower low-density…
Read More...
Read More...
Bristol Myers Squibb Expands AI Push With Anthropic
Bristol Myers Squibb and Anthropic have entered a strategic agreement to deploy Anthropic’s Claude artificial intelligence platform across Bristol Myers Squibb’s global operations,…
Read More...
Read More...
Lilly’s Retatrutide Shows Strong Weight Loss in Phase 3
Eli Lilly and Company reported positive topline results from its Phase 3 TRIUMPH-1 clinical trial, showing that investigational obesity treatment retatrutide delivered substantial and…
Read More...
Read More...
Gilead Completes $3.15 Billion Tubulis Acquisition
Gilead Sciences has completed its previously announced acquisition of Germany-based biotechnology company Tubulis GmbH, strengthening its oncology pipeline with next-generation…
Read More...
Read More...
QIAGEN, NVIDIA Expand AI Drug Discovery Collaboration
QIAGEN announced a new collaboration with NVIDIA aimed at integrating accelerated computing and artificial intelligence into drug discovery workflows, a move the company says could help…
Read More...
Read More...
GSK Partners With Sino Biopharmaceutical on Hepatitis B Drug
GSK has announced an exclusive strategic collaboration with Sino Biopharmaceutical through its subsidiary Chia Tai Tianqing Pharmaceutical Group to accelerate the launch and…
Read More...
Read More...
Roche Acquires PathAI to Expand Digital Pathology Business
Swiss healthcare giant Roche has signed a definitive merger agreement to acquire U.S.-based artificial intelligence pathology company PathAI, strengthening its position in the rapidly…
Read More...
Read More...
